Crohn's Disease and Escherichia coli
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date1997/12/01
-
Indian UGC (journal)
-
Refrences48
-
Citations226
-
Helmut A. Malchow
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the digestive system
Gastroenterology
Medicine
Medicine (General)
You May Also Like
- Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress
- Pharmacology of proton pump inhibitors
- Epidemiology and risk factors for gallstone disease: Has the paradigm changed in the 21st century?
- Butyrate Enhances Intestinal Epithelial Barrier Function via Up-Regulation of Tight Junction Protein Claudin-1 Transcription
- Oxidative Stress and Pathogenesis of Inflammatory Bowel Disease: An Epiphenomenon or the Cause?
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| 10.1056/NEJM199606133342401 | New England Journal of Medicine |
| 1996 | |
| Short-Chain Fatty Acids in the Human Colon: Relation to Gastrointestinal Health and Disease | Scandinavian Journal of Gastroenterology |
| 331 | 1996 |
| 5-Aminosalicylsäure in der Rezidivprophylaxe des Morbus Crohn | DMW - Deutsche Medizinische Wochenschrift |
| 1995 | |
| Immunocytochemical evidence of Listeria, Escherichia coil, and Streptococcus antigens in Crohn's disease | Gastroenterology |
| 195 | 1995 |
Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) | Clinical and Experimental Immunology |
| 586 | 1995 |
Refrences Analysis
The category
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology 39
is the most frequently represented among the references in this article. It primarily includes studies from Gastroenterology and Gut. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Probiotics for inflammatory bowel disease: Is there sufficient evidence? | Open Life Sciences |
| 2024 | |
| Nanoprobiotics for Remolding the Pro-inflammatory Microenvironment and Microbiome in the Treatment of Colitis | Nano Letters |
| 4 | 2023 |
| The Efficacy and Role of Probiotics for Maintenance of Remission in Crohn’s Disease: A Meta-Analysis and Survey | Open Journal of Gastroenterology | 2023 | ||
| Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004 | Zeitschrift für Gastroenterologie |
| 38 | 2022 |
| Prospective and challenges of live bacterial therapeutics from a superhero Escherichia coli Nissle 1917 | Critical Reviews in Microbiology |
| 1 | 2022 |
Citations Analysis
The category
Medicine: Medicine (General) 100
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled NOVEL THERAPIES FOR INFLAMMATORY BOWEL DISEASE and was published in 1999. The most recent citation comes from a 2024 study titled Probiotics for inflammatory bowel disease: Is there sufficient evidence?. This article reached its peak citation in 2006, with 20 citations. It has been cited in 146 different journals, 14% of which are open access. Among related journals, the Alimentary Pharmacology & Therapeutics cited this research the most, with 9 citations. The chart below illustrates the annual citation trends for this article.